1. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study;Channick;Lancet,2001
2. Bosentan therapy for pulmonary arterial hypertension;Rubin;N Engl J Med,2002
3. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study;Barst;Chest,2002
4. Complete results of the first randomized, placebo-controlled study of bosentan, a dual endothelin receptor antagonist, in pulmonary arterial hypertension;Badesch;Curr Ther Res Clin Exp,2002
5. Clinical pharmacology of bosentan, a dual endothelin receptor antagonist;Dingemanse;Clin Pharmacokinet,2004